Notice of AGM and AIM Rule 15 Update

11 September 2020

Phimedix Plc

("Phimedix" or "the Company")

Notice of Annual General Meeting and AIM Rule 15 Update

Phimedix (AIM: PHM) confirms that the Annual Report & Accounts for the year ended 31 March 2020, together with the Notice of its Annual General Meeting ("AGM") and Form of Proxy, have been posted to shareholders and are available on the Company's website www.phimedix.com. The AGM is to be held at 10.00 a.m. on 5 October 2020, at Bracher Rawlins LLP, 77 Kingsway, London WC2B 6SR.

In accordance with Government legislation and related restrictions in response to COVID-19, and to minimise public health risks, the General Meeting is to be held as a closed meeting unless both the coronavirus (COVID-19) situation and the applicable guidance have changed prior to the date of the meeting. Unless Shareholders are notified otherwise by the Company prior to the date of the General Meeting, the arrangements for the meeting shall be that neither Shareholders, nor their proxies nor corporate representatives will be permitted to attend the meeting in person.  As such, Shareholders are strongly encouraged to appoint the Chairman of the General Meeting to act as their proxy as no other person will be permitted to attend the meeting.

AIM Rule 15 update

The London Stock Exchange is expected to suspend trading in the Company's ordinary shares on AIM, pursuant to Rule 15 of the AIM Rules, at 7.30 am on 14 September 2020.  In the event that no reverse takeover is completed in the six months after that date, the London Stock Exchange will cancel the admission of the Company's ordinary shares to trading on AIM.